Fast Five Quiz: Heart Failure Comorbidities

Ioana Dumitru, MD


July 15, 2021

A regimen of intravenous iron therapy in iron-deficient patients with HF may improve HF-related symptoms and quality of life as well as exercise tolerance. However, it remains unknown whether intravenous iron supplements confer benefit when it comes to other outcomes, such as HF hospitalizations, cardiovascular-related mortality, and all-cause mortality.

In addition, achieving diabetes therapy targets may also confer beneficial effects on HF-related symptoms and health-related quality of life. Intensive treatment to achieve low A1c targets lessens the long-term risk for microvascular events, such as retinopathy, nephropathy, and peripheral neuropathy. Intensive glycemic control may also minimize the risk for nonfatal myocardial infarction.

Learn more about HF guidelines.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.